Since IFN-α is a potent inducer of CXCL10 [26], high levels of CXCL10 in early RA, despite lower proportions of Th1 cells, may suggest that type I IFN-dependent immune mechanisms could be important in preclinical and early RA. The gene discussed is CXCL10; the disease is rheumatoid arthritis.